CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[( METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAM ATE OR COBICISTAT

CRYSTALLINE FORM OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5-{[(2S)-2-[( METHYL{[2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL 9AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAM ATE OR COBICISTAT

The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). La invención proporciona una forma cristalina del compuest...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hector Novoa DE ARMAS, Chiajen LAI, Richard Hung Chiu YU, Lok Him Lawrence YU
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a crystalline form of the compound of formula (Ia), methods for making the crystalline form of the compound of formula (Ia), and therapeutic methods for the use of the crystal line form of the compound of formula (Ia). La invención proporciona una forma cristalina del compuesto de fórmula (Ia), métodos para producir la forma cristalina del compuesto de fórmula (Ia) y métodos terapéuticos para el uso de la forma cristalina del compuesto de fórmula (Ia).